IE38423L - Neonatal calf diarrhea vaccine. - Google Patents
Neonatal calf diarrhea vaccine.Info
- Publication number
- IE38423L IE38423L IE731925A IE192573A IE38423L IE 38423 L IE38423 L IE 38423L IE 731925 A IE731925 A IE 731925A IE 192573 A IE192573 A IE 192573A IE 38423 L IE38423 L IE 38423L
- Authority
- IE
- Ireland
- Prior art keywords
- vaccine
- calf diarrhea
- bovine
- virus
- coronavirus
- Prior art date
Links
- 206010012735 Diarrhoea Diseases 0.000 title abstract 5
- 244000309466 calf Species 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 241000283690 Bos taurus Species 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 3
- 241000711573 Coronaviridae Species 0.000 abstract 2
- 230000002238 attenuated effect Effects 0.000 abstract 2
- 241001112696 Clostridia Species 0.000 abstract 1
- 241000588724 Escherichia coli Species 0.000 abstract 1
- 241000702263 Reovirus sp. Species 0.000 abstract 1
- 229940001442 combination vaccine Drugs 0.000 abstract 1
- 230000000415 inactivating effect Effects 0.000 abstract 1
- 244000052769 pathogen Species 0.000 abstract 1
- 230000005855 radiation Effects 0.000 abstract 1
- 241000701161 unidentified adenovirus Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
1401565 Calf diarrhea vaccine UNIVERSITY OF NEBRASKA REGENTS OF 23 Oct 1973 [30 Oct 1972] 49253/73 Heading A5B A calf diarrhea vaccine comprises an attenuated or inactivated coronavirus-like calf diarrhea virus. The vaccine may be in the form of a combination vaccine comprising inactivated coronavirus and reovirus, both of which are prepared by inactivating a live virus, either unaaatenuated or attenuated, by chamicals, radiation or heat. Coronavirus can also be combined with bovine adenovirus, bovine virus diarrhea, or other bovine pathogens such as E. Coli or clostridia sp.
[GB1401565A]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30217972A | 1972-10-30 | 1972-10-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE38423L true IE38423L (en) | 1974-04-30 |
| IE38423B1 IE38423B1 (en) | 1978-03-15 |
Family
ID=23166611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE1925/73A IE38423B1 (en) | 1972-10-30 | 1973-10-26 | Vaccine for nenatal calf diarrhea |
Country Status (17)
| Country | Link |
|---|---|
| JP (3) | JPS5817169B2 (en) |
| AR (1) | AR200155A1 (en) |
| AU (1) | AU476160B2 (en) |
| BE (1) | BE806568A (en) |
| CA (1) | CA1019675A (en) |
| CH (1) | CH596315A5 (en) |
| DD (1) | DD110517A5 (en) |
| DE (1) | DE2354324C2 (en) |
| ES (1) | ES419996A1 (en) |
| FI (1) | FI52740C (en) |
| FR (1) | FR2204405B1 (en) |
| GB (1) | GB1401565A (en) |
| HU (1) | HU168486B (en) |
| IE (1) | IE38423B1 (en) |
| NL (1) | NL7314293A (en) |
| SE (1) | SE419500B (en) |
| ZA (1) | ZA738329B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6027007U (en) * | 1983-07-30 | 1985-02-23 | 株式会社 協立双葉自動機 | Labeling machine with container rotation speed adjustment device |
| JPH0518338Y2 (en) * | 1985-12-27 | 1993-05-17 | ||
| ZA872532B (en) * | 1986-04-21 | 1987-11-25 | Akzo Nv | Combined vaccine |
| US6291228B1 (en) | 1988-08-03 | 2001-09-18 | Vericore Limited | Vaccine |
| GB8818415D0 (en) * | 1988-08-03 | 1988-09-07 | Animal Health Inst | Vaccine |
| JPH08786B2 (en) * | 1993-02-25 | 1996-01-10 | 株式会社微生物化学研究所 | Bovine coronavirus infectious disease vaccine |
| EP3372677B8 (en) | 2015-11-06 | 2019-09-25 | Asahi Kasei Medical Co., Ltd. | Method for producing parvovirus having high infectivity titer and high purity |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE759425A (en) * | 1969-11-28 | 1971-05-25 | Mebus Charles A | CALVES DIARRHEA VACCINES, THEIR PREPARATION AND USE |
| US3629413A (en) * | 1970-02-04 | 1971-12-21 | Univ Southern Illinois | Polyvalent bovine vaccines and methods of making and using same |
-
1973
- 1973-10-16 SE SE7314001A patent/SE419500B/en unknown
- 1973-10-17 NL NL7314293A patent/NL7314293A/xx unknown
- 1973-10-23 AR AR250655A patent/AR200155A1/en active
- 1973-10-23 GB GB4925373A patent/GB1401565A/en not_active Expired
- 1973-10-24 AU AU61774/73A patent/AU476160B2/en not_active Expired
- 1973-10-26 BE BE137108A patent/BE806568A/en not_active IP Right Cessation
- 1973-10-26 ES ES419996A patent/ES419996A1/en not_active Expired
- 1973-10-26 DD DD174314A patent/DD110517A5/xx unknown
- 1973-10-26 IE IE1925/73A patent/IE38423B1/en unknown
- 1973-10-29 FI FI733344A patent/FI52740C/en active
- 1973-10-29 ZA ZA738329A patent/ZA738329B/en unknown
- 1973-10-29 CA CA184,534A patent/CA1019675A/en not_active Expired
- 1973-10-29 CH CH1521373A patent/CH596315A5/xx not_active IP Right Cessation
- 1973-10-30 DE DE2354324A patent/DE2354324C2/en not_active Expired
- 1973-10-30 JP JP48122156A patent/JPS5817169B2/en not_active Expired
- 1973-10-30 HU HU73BO1469A patent/HU168486B/en unknown
- 1973-10-30 FR FR7338701A patent/FR2204405B1/fr not_active Expired
-
1978
- 1978-10-13 JP JP12675178A patent/JPS5531058A/en active Granted
-
1981
- 1981-12-28 JP JP56215939A patent/JPS57131726A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| HU168486B (en) | 1976-05-28 |
| GB1401565A (en) | 1975-07-16 |
| ES419996A1 (en) | 1976-08-01 |
| FI52740B (en) | 1977-08-01 |
| JPS5817169B2 (en) | 1983-04-05 |
| BE806568A (en) | 1974-04-26 |
| FI52740C (en) | 1977-11-10 |
| SE419500B (en) | 1981-08-10 |
| AU6177473A (en) | 1975-04-24 |
| JPS4980230A (en) | 1974-08-02 |
| FR2204405B1 (en) | 1977-01-28 |
| AU476160B2 (en) | 1976-09-16 |
| JPS5531058A (en) | 1980-03-05 |
| JPS6124370B2 (en) | 1986-06-10 |
| DE2354324C2 (en) | 1982-06-03 |
| CA1019675A (en) | 1977-10-25 |
| DE2354324A1 (en) | 1974-05-09 |
| FR2204405A1 (en) | 1974-05-24 |
| NL7314293A (en) | 1974-05-02 |
| IE38423B1 (en) | 1978-03-15 |
| JPS5757449B2 (en) | 1982-12-04 |
| JPS57131726A (en) | 1982-08-14 |
| CH596315A5 (en) | 1978-03-15 |
| ZA738329B (en) | 1974-09-25 |
| AR200155A1 (en) | 1974-10-24 |
| DD110517A5 (en) | 1974-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1190792B (en) | PROCEDURE FOR PREPARING BLOOD COAGULANT ENZYME COMPOSITIONS | |
| ATE219948T1 (en) | RECOMBINANT VACCINES THAT CONTAIN IMMUNOGENE ATTENUATE RPOS-POSITIVE PHENTOTYPE BACTERIA | |
| DK26081A (en) | GENETICALLY WEAKED BACTERIA VACCINES WITH MULTIPLE MUTATIONS OF THE SAME PHENOTYPE | |
| CA2022420A1 (en) | Escherichia coli vaccine | |
| ES254659U (en) | Deformable light-weight housing structure | |
| NO904538D0 (en) | CHEMICAL GYCLOPROTEINS CONTAINING IMMUNOGENIC SEGMENTS OF HUMANT PARAINFLUENNAVIRUS TYPE 3. | |
| NO912825L (en) | PROCEDURE FOR THE PREPARATION OF COCONJUGATE VACCINES INCLUDING IM MUNOGENT PROTEIN, HIV RELATED PEPTIDES AND ANIONIC GROUPS. | |
| NZ314585A (en) | Method of treating H. Pylori associated gastroduodenal disease | |
| IE38423L (en) | Neonatal calf diarrhea vaccine. | |
| ES2089923T3 (en) | COMPOSITION OF A LIVING RECOMBINANT SUBUNITARY VACCINE AND PREPARATION PROCEDURE. | |
| IT1044555B (en) | Benzodipyrones - used for treatment of allergic asthma | |
| SE7512828L (en) | CALICIVIRUSVACCIN | |
| TW340873B (en) | Chicken anaemia agent vaccine | |
| DK398683D0 (en) | PROCEDURE FOR MANUFACTURING ANTIBODIES | |
| EP0028172A3 (en) | Anticolibacillary animal vaccine, preparation, application and used escherichia coli strains | |
| NL300073I1 (en) | Vaccine. | |
| DE3361138D1 (en) | Ozone inactivated organisms as vaccines | |
| IT8020442A0 (en) | PROCEDURE, USE THEREOF AND DEVICE FOR HANDLING PRINTED PRODUCTS. | |
| SE7711433L (en) | TRICYCLIC ASSOCIATIONS | |
| JPS5213146A (en) | Infrared ray radiator | |
| SU565653A1 (en) | Method of preservation of bone tissue | |
| GB1036621A (en) | Improvements in or relating to bacterial vaccines | |
| before Parliament et al. | The Industrial Relations (Code of Practice) Order 1972 | |
| Nicolas et al. | Attempt of Vaccination Program Against Sheep Salmonellosis due to Salmonella abortus ovis. | |
| JPS5359023A (en) | Inactivation of toxins produced by microbials and attenuation of vaccines |